Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery

ClinicalTrials.gov ID: NCT01440751

Public ClinicalTrials.gov record NCT01440751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 9:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparative Study of the Safety and Effectiveness of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery

Study identification

NCT ID
NCT01440751
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Aeon Astron Europe B.V.
Industry
Enrollment
99 participants

Conditions and interventions

Conditions

Interventions

  • Use of Mitomycin-C (MMC) in trabeculectomy Drug
  • Use of ologen Collagen Matrix in trabeculectomy (ologen) Device

Drug · Device

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2011
Primary completion
Nov 30, 2013
Completion
Nov 30, 2015
Last update posted
Oct 31, 2017

2011 – 2015

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
VoldVision-Holf Eye Clinic Rogers Arkansas 72756
Northwestern Memorial Hospital Chicago Illinois 60611
Institue of Ophthalmology and Visual Science Newark New Jersey 07103
Glaucoma Associates of New York New York New York 10003
New York Eye and Ear Infirmary New York New York 10003
Dean McGee Eye Institue Oklahoma City Oklahoma 73104
Wills Eye Institue Philadelphia Pennsylvania 19107
Glaucoma Associates of Texas Dallas Texas 75231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01440751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2017 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01440751 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →